Soraya Wuilleme

Soraya Wuilleme

Auto-generated profile, based on publicly available information

Soraya Wuilleme

Hematology Biology Nantes University Hospital Nantes France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VBVéronique Baccini
Véronique Baccini
FGFranck Geneviève
Franck Geneviève
HJHugues Jacqmin
Hugues Jacqmin
CBChatelain bernard
Chatelain bernard
SGSandrine Girard
Sandrine Girard
BVBardet Valerie
Bardet Valerie
Despite the ongoing development of automated hematology analyzers to optimize complete blood count results, platelet count still suffers from pre-analytical or analytical pitfalls, including EDTA-induced pseudothrombocytopenia. Although most of these interferences are widely known, laboratory practices remain highly heterogeneous. In order to harmonize and standardize cellular hematology practices, the French-speaking Cellular Hematology Group (GFHC) wants to focus on interferences that could affect the platelet count and to detail the verification steps with minimal recommendations, taking into account the different technologies employed nowadays. The conclusions of the GFHC presented here met with a "strong professional agreement" and are explained with their rationale to define the course of actions, in case thrombocytopenia or thrombocytosis is detected. They are proposed as minimum recommendations to be used by each specialist in laboratory medicine who remains free to use more restrictive guidelines based on the patient’s condition.

31 March 2014 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
NRNelly Robillard
Nelly Robillard
SWSoraya Wuillã¨mE
Soraya Wuillã¨mE
PMPhilippe Moreau
Philippe Moreau
Marie BénéMarie Béné
Marie Béné
Plasma-cells are essentially characterized by the co-expression of CD138 and CD38, which allows their identification in flow cytometry in bone marrow, peripheral blood or cell suspensions from tissues. These terminally differentiated B-cells may lose the expression of surface CD19 and that of CD20 while retaining CD27. When malignant, they can gain a number of other markers such as CD28, CD33, CD56 or CD117 and lose CD27. Moreover, since each plasma cell is only able to produce a single type of immunoglobulins, they display isotypic restriction and clonal malignant plasma cells can be further characterized by their homogeneous expression of either kappa or lambda light chains. In multiple myeloma (MM), such plasma cell clones produce the immunoglobulin identified in plasma as an abnormal peak. In the bone marrow where they essentially accumulate, these plasma cells may however display various immunophenotypes. The latter were explored in a two-way approach. Firstly the various subsets delineated by the selective or common expression of CD19 together with combined CD56/CD28 were explored in normal and MM bone marrow. Then other aberrant markers’ expression was investigated, i.e. CD20, CD27, CD33, CD56, CD117. These data were compared to literature information. They underline the vast heterogeneity of MM plasma cells possibly accounting for the various answers to therapy of MM patients.

15 June 2020 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
CDCamille Debord
Camille Debord
SWSoraya Wuillème
Soraya Wuillème
BEbene Eveillard
bene Eveillard
OTOlivier Theisen
Olivier Theisen
CGCatherine Godon
Catherine Godon
Marie BénéMarie Béné
Marie Béné

16 January 2025 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
SWSoraya Wuilleme
Soraya Wuilleme
SGSandrine Girard
Sandrine Girard
MSMichel Soulard
Michel Soulard
BCBernard Chatelain
Bernard Chatelain
EEElodie Etienne
Elodie Etienne
BVBardet Valerie
Bardet Valerie

12 July 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
CLCamille Lours
Camille Lours
LCLaurane Cottin
Laurane Cottin
MWMargaux Wiber
Margaux Wiber
VAValérie Andrieu
Valérie Andrieu
VBVéronique Baccini
Véronique Baccini
JLJean-François Lesesve
Jean-François Lesesve
In order to standardize cellular hematology practices, the French-speaking Cellular Hematology Group (Groupe Francophone d’Hématologie Cellulaire, GFHC) focused on Perls’ stain. A national survey was carried out, leading to the proposal of recommendations on insoluble iron detection and quantification in bone marrow. The criteria presented here met with a “strong professional agreement” and follow the suggestions of the World Health Organization’s classification of hematological malignancies.

1 January 2021 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
CDCamille Debord
Camille Debord
JBJessie Bourcier
Jessie Bourcier
FSFrançois Subiger
François Subiger
FLFrançois Leclair
François Leclair
CTCyrille Touzeau
Cyrille Touzeau
SWSoraya Wuillème
Soraya Wuillème